Navigation Links
Novel test for bowel cancer

Researchers have developed a rapid and infallible test for bowel cancer based upon a molecule found only in cancer cells. We already know that bowel cancer is highly curable if caught early. Screening with sigmoidoscopy - an internal exam// of the bowel can reduce the incidence of the disease. Now researchers in the find that a reliable test can also be done on samples of feces.

The bowel sheds cells into feces all the time. The researchers have based their test upon the presence or absence of a molecule called MCM2, which is indicative of cell division. It is found only in cells that are actively dividing - that is, pre-cancerous or cancerous cells. In a trial, involving both bowel cancer patients and healthy controls, 30 out of 45 in the patient group tested positive for MCM2, compared to none in the control group.

It's an exciting development - but more research is needed to assess the role of the MCM2 test. The researchers think it may best be employed in conjunction with sigmoidoscopy, to pick up more early cancers. It may also be applied to the detection of other cancers, where MCM2 could play a role.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 15, 2018 , ... LGC Maine Standards ... Number 205bf, for easier linearity and calibration verification. , The kit, in ... verification and verification of the reportable range for Albumin (ALB), Amylase (AMY), Cholesterol ...
(Date:10/16/2018)... (PRWEB) , ... October 16, ... ... a Texas-based healthcare and clinical research networking-technology company founded by patient-survivors, and ... quality and compliance in the clinical trial execution process, today announced its ...
(Date:10/13/2018)... ... 2018 , ... Convoy of Hope’s Disaster Services Team is currently in Marianna, ... set up to serve hurricane survivors with water, food, baby products, hygiene kits, flood ... additional truckloads of supplies are in motion to Florida. , Convoy’s walk-up ...
(Date:10/11/2018)... CHURCH, Va. (PRWEB) , ... October 11, 2018 ... ... and services, today announced the acquisition of J.Lodge, an industry leader in contact ... story —a lifelong survivor of a debilitating medical condition—J. Lodge supports alternative work ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... and quite vulnerable to manipulation,” warns former U.S. Department of Homeland Security deputy ... We’re Vulnerable and How We Can Stop it. , Pointing to the ability ...
Breaking Medicine News(10 mins):
(Date:10/13/2018)... ... October 12, 2018 , ... ... open, welcoming applications from healthcare providers, students, trainees, and researchers worldwide. Winning proposals ... as microbiome sequencing and bioinformatics services. , “uBiome is thrilled to further expand ...
(Date:10/13/2018)... Fla. (PRWEB) , ... October 13, 2018 , ... In ... period taking on one massive brand after another. 2018 has been a game-changing year ... categories have all played a large role in the growth. Ion Labs attributes its ...
(Date:10/11/2018)... ... 11, 2018 , ... In the last four months it has also obtained ... allowance of six more in USA, China and Japan from three other patent families ... and security products. , The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic ...
Breaking Medicine Technology: